All Basal Insulins Are Not Created Equal: Comparative PK/PD, Efficacy, Side Effect (Hypoglycemia), and Safety Profiles for Established and New Longer-Acting Basal Insulins—A Translational Roadmap for the Diabetes Specialist
Related Presenters
Guillermo E. Umpierrez, MD, CDE
Professor of Medicine
Emory University
Section Head, Diabetes & Endocrinology
Atlanta, GA
Editor-in-Chief
BMJ Open Diabetes Research & Care